IADSA update on international supplement regulations

Market Alerts

July 2022

June 2022

May 2022

April 2022

February 2022

November 2021

  • SCNM Dedicates Ric Scalzo Institute of Botanical Research
  • August 2021

    July 2021

    March 2021

    February 2021

    November 2020

    October 2020

    September 2020

    August 2020

    July 2020

    June 2020

    April 2020

    February 2020

    January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities
  • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    IADSA update on international supplement regulations

    April 2020 IADSA Newsflash

    Published: Tuesday, March 31, 2020

    AHPA is an active member of IADSA and is distributing the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash covers:

    • The European Commission has issued a draft regulation directed at botanicals containing hydroxyanthracene derivatives (HADs) (typically used to support bowel function as supplements). NOTE: AHPA plans to submit comments via the feedback process; comments are due by April 22nd.
    • Belgium recently published guidance on the analysis for four new plants.
    • Ireland found in a survey of cannabidiol (CBD) products that a majority were not in compliance with various regulations that apply to such products, such as variations in the amount of CBD versus label declarations, unauthorized health claims, and failure to properly notice the product for marketing.
    • Norway has initiated a risk assessment of caffeine that will include consideration of total caffeine exposure from multiple sources.
    • Poland has set a daily limit of 3 g for Withania somnifera along with a label warning of potential drug interactions.
    • United kingdom set a deadline of March 31, 2021 for companies to submit novel food applications for CBD-containing products.
    • United Kingdom is investigating the safety of turmeric and curcumin products.
    • Uruguay has issued directives regarding the use of non-psychoactive derivatives of cannabis in food and food supplements.

    Download the April 2020 issue >>

    Print

    2022 Annual Fund Sponsors

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.